Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatropin for neuromuscular changes in children born small for gestational age
2006-004304-39Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Dec 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of somatropin in Short stature in children born small for gestational age and Small for gestational age (SGA), sponsored by Pfizer. Primary endpoint: Change in efficiency of muscular function. Started Dec 2007; status: terminated.
02
Drugs
somatropin
03
Conditions
Short stature in children born small for gestational ageSmall for gestational age (SGA)
Beyond the preview
Go deeper on 2006-004304-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004304-39.